As innovative patient care models are tested and put into practice,
new studies show the value of compliance-prompting designs.
Packaging that promotes compliance will receive increased attention as governments and private insurers seek to ensure patient safety and reduce healthcare costs.
Studies have shown, for example, that achieving high adherence levels in typically low-compliance therapies such as diabetes, cholesterol, and high blood pressure can reduce healthcare costs by 40 to 50%.
Packaging can be an important part of a solution that includes caregiver support and intervention, but adherence and persistence with medications requires patient buy-in, presenters sa